Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Sleep Apnea
Interventions: NightOwl; Device
Lead sponsor: Ectosense NV; Industry
Eligibility: 13 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: Coral Springs, Florida • Hollywood, Florida • Miami Lakes, Florida + 1 more

Conditions: Autism Spectrum Disorder, Sleep Disorder, Neurological Disorder, Sleep Disturbance
Interventions: Tasimelteon Oral Capsule, Tasimelteon Liquid Suspension; Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 2 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: San Jose, California • San Leandro, California • Santa Monica, California + 2 more

Conditions: Narcolepsy
Interventions: ADX-N05, Placebo; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 10
States / cities: Phoenix, Arizona • St. Petersburg, Florida • Atlanta, Georgia + 6 more

Conditions: TBI, Insomnia
Interventions: Sleep Education, Cognitive Behavior Therapy for Insomnia; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obstructive Sleep Apnea
Interventions: Toffee Full Face Mask; Device
Lead sponsor: Fisher and Paykel Healthcare; Industry
Eligibility: 22 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Sleep Apnea, Obstructive, Sleep Apnea, Central
Interventions: DreamKit; Device
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 7
States / cities: Birmingham, Alabama • Colorado Springs, Colorado • Lehigh Acres, Florida + 4 more

Conditions: Delayed Sleep-Wake Phase Disorder
Interventions: Amber Glasses, Clear Lens Glasses; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 14 Years to 17 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois • Rochester, Minnesota

Conditions: Narcolepsy
Interventions: Xyrem, Xyrem Placebo, Modafinil at established dose, Modafinil (Placebo); Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 36
States / cities: Phoenix, Arizona • Fullerton, California • Los Angeles, California + 29 more

Conditions: Sleep, Pollution; Exposure, Cough
Interventions: CARDIO® salmon oil; Dietary Supplement
Lead sponsor: Hofseth Biocare ASA; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
Interventions: True group auricular acupuncture, Sham group auricular acupuncture, Wait-List Control Group; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Insomnia, Pain
Interventions: CBT for Insomnia (CBT-I), CBT for Pain (CBT-P); Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 35 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Sleepiness, Daytime
Interventions: LED bright light treatment device; Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Sleep Initiation and Maintenance Disorders, Depression
Interventions: Eszopiclone, Fluoxetine, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Sleep Apnea, Obstructive
Interventions: Placebo pill, Sedative, Room air, Oxygen; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Apnea, Obstructive
Interventions: Desipramine, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Disturbance, Heart Failure
Interventions: Zolpidem Tartrate, Placebo oral capsule; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 79 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sleep Disorder
Interventions: CPC M1; Device
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Chronic Disease, Obesity, Sleep Disorder, Depression
Interventions: Lifestyle Medicine; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Restless Legs Syndrome
Interventions: NTX100 Neuromodulation System; Device
Lead sponsor: Noctrix Health, Inc.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 7
States / cities: San Leandro, California • Colorado Springs, Colorado • Atlanta, Georgia + 4 more

Conditions: Polypharmacy, Insomnia, Anticoagulants
Interventions: Academic Detailing (AD), LEAP; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea, Malocclusion
Interventions: Not listed
Lead sponsor: Mohamed Bazina; Other
Eligibility: 10 Years to 15 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Idiopathic Hypersomnia, Excessive Daytime Sleepiness
Interventions: Pitolisant; Drug
Lead sponsor: Harmony Biosciences Management, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 32
States / cities: Los Angeles, California • San Ramon, California • Brandon, Florida + 29 more

Conditions: Caffeine Dependence, Anxiety, Sleep Disturbance, Gastrointestinal Dysfunction, Sleep Initiation and Maintenance Disorders, Caffeine; Sleep Disorder, Caffeine, Caffeine-Induced Anxiety Disorder, Caffeine Withdrawal, Caffeine-Induced Sleep Disorder, Without Use Disorder, Caffeine Abuse, Insomnia, Anxiety Disorders, Sleep Disorder, Heartburn, Diarrhea
Interventions: Caffeine Reduction Manual; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Opioids, Obstructive Sleep Apnea (OSA)
Interventions: Morphine p.o., Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Validation Study of the NightOwl Home Sleep Apnea Test

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)

The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea

DreamKit Diagnostic Validation

Glasses for Adolescent Delayed Sleep-Wake Phase Disorder

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Investigating the Effect of Daily CARDIO® Capsules Supplementation on Improved Sleep in Healthy, Urban-Dwelling Adults

Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder

Treatment of Insomnia Secondary to Chronic Pain

Effects of Litebook EDGE™ Phototherapy on Academic Performance and Brain Activity

Improving Sleep and Psychological Functioning in People With Depression and Insomnia

Combination Therapy to Treat Sleep Apnea

Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B

Improving Sleep Quality in Heart Failure

Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device

Virtual Lifestyle Medicine Comparative Effectiveness Research

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

Premolar Extractions for Obstructive Sleep Apnea in Children With Overjet

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia

Remote Guided Caffeine Reduction

Impacts of Opioids on Respiratory Drive During Sleep